New Yorkers need access to biomarker testing

 “We have the opportunity to reaffirm New York’s position as a nationwide leader in the treatment of disease and prioritization of medical innovation.”

NewYorkBIO’s CEO Jennifer Hawks Bland recently published a letter in The Buffalo News, calling on Governor Hochul to sign the crucial Senate Bill 1196a/Assembly Bill 1673a into law. Read more about why NewYorkBIO is seeking to ensure access to biomarker testing to advance overall health outcomes: https://buffalonews.com/opinion/another-voice-new-yorkers-need-access-to-biomarker-testing/article_d5bb5d58-7ce7-11ee-b9db-d772dc648621.html